BahnRS, BurchHB, CooperDS, GarberJR, GreenleeMC, KleinI, LaurbergP, McDougallR, MontoriVM, RivkeesSA, RossDS, SosaJA, StanMN. 2011. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21:593–646.
2.
KahalyGJ, BartalenaL, HegedüsL. 2011. The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective. Thyroid, 21:585–591.
3.
YamashitaS, AminoN, ShongYK. 2011. The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: viewpoints from Japan and Korea. Thyroid, 21:577–580.
4.
BiondiB, CooperD. 2008. The clinical significance of subclinical thyroid dysfunction. Endocr Rev, 29:76–131.
5.
RazviS, ShakoorA, VanderpumpM, WeaverJU, PearceSH. 2008. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta-analysis. J Clin Endocrinol Metab, 93:2998–3007.
6.
RodondiN, den ElzenWP, BauerDC, CappolaAR, RazviS, WalshJP, AsvoldBO, IervasiG, ImaizumiM, ColletTH, BremnerA, MaisonneuveP, SgarbiJA, KhawKT, VanderpumpMP, NewmanAB, CornuzJ, FranklynJA, WestendorpRG, VittinghoffE, GusseklooJ. 2010. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304:1365–1374.
7.
GusseklooJ, van ExelE, de CraenAJ, MeindersAE, FrolichM, WestendorpRG. 2004. Thyroid status, disability and cognitive function, and survival in old age. JAMA, 292:2591–2599.
8.
ParleJ, RobertsL, WilsonS, PattisonH, RoalfeA, HaqueMS, HeathC, SheppardM, FranklynJ, HobbsFD. 2010. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab, 95:3623–32.
9.
ParleJV, FranklynJA, CrossKW, JonesSR, SheppardMC. 1993. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract, 43:107–109.
BauerDC, EttingerB, NevittMC, StoneKL. 2001. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med, 134:561–568.
12.
TurnerMR, CamachoX, FischerHD, AustinPC, AndersonGM, RochonPA, LipscombeLL. 2011. Levothyroxine dose and risk of fractures in older adults: a nested case-control study. BMJ, 342:d2238.
13.
MitchellAL, HickeyB, HickeyJL, PearceSHS. 2009. Trends in thyroid prescribing and consumption in the UK. BMC Public Health, 9:132.
14.
NegroR, SchwartzA, GismondiR, TinelliA, MangieriT, Stagnaro-GreenA. 2010. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab, 95:1699–707.
